We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Platelet Activation in Chronic Inflammatory Skin Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01759693
Recruitment Status : Unknown
Verified December 2012 by Meir Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : January 3, 2013
Last Update Posted : January 3, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Platelets are blood cells that are important in coagulation of the blood. These cells have recently been shown to play a role in a number of other biologic processes, for example inflammation. In this study the investigators will determine the extent of platelet activation in people suffering from common chronic skin inflammation-urticaria and allergic dermatitis.

Condition or disease Intervention/treatment
Urticaria Atopic Dermatitis Procedure: Blood sampling

Study Design

Study Type : Observational
Estimated Enrollment : 80 participants
Observational Model: Case Control
Time Perspective: Prospective
Study Start Date : February 2013
Estimated Primary Completion Date : August 2013
Estimated Study Completion Date : October 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Skin disease
Patients with urticaria or atopic dermatitis
Procedure: Blood sampling
Blood sampling
Control
Healthy volunteers
Procedure: Blood sampling
Blood sampling


Outcome Measures

Primary Outcome Measures :
  1. Platelet activation [ Time Frame: 6 months ]
    Platelet function will be assessed at enrollment


Secondary Outcome Measures :
  1. Mean platelet volume [ Time Frame: 6 months ]
    Mean platelet volume will be assessed at enrollment


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Hospital clinic
Criteria

Inclusion Criteria: Urticaria or atopic dermatitis -

Exclusion Criteria:Lack of informed consent

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01759693


Locations
Israel
Meir Medical Center Not yet recruiting
Kfar Saba, Israel, 44281
Contact: Martin H Ellis, MD    972-9-7471822    martinel@clalit.org.il   
Sub-Investigator: Martin H Ellis, MD         
Sponsors and Collaborators
Meir Medical Center
More Information

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01759693     History of Changes
Other Study ID Numbers: 0113
MMC 0113 ( Other Identifier: Meir Medical Center )
First Posted: January 3, 2013    Key Record Dates
Last Update Posted: January 3, 2013
Last Verified: December 2012

Keywords provided by Meir Medical Center:
Platelet activation

Additional relevant MeSH terms:
Dermatitis
Dermatitis, Atopic
Eczema
Urticaria
Skin Diseases
Skin Diseases, Genetic
Genetic Diseases, Inborn
Skin Diseases, Eczematous
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Skin Diseases, Vascular